Johannes Gutenberg-Universität Mainz
Saarstr. 21, 55099 Mainz
- 6131/39-0
Forschungsprojekte
Ergebnisse pro Seite:
10
2018 - 2020
INCB 54828-201: A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations- Prof. Dr. Igor,
- PD Dr. Thomas,
- PD Dr. Wolfgang
2018 - 2023
Exploring DNA methylation/gene silencing patterns in MDS/AML for potential therapeutic Targets- Dr. Borhane
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. Georg,
- Prof. Dr. Igor,
- PD Dr. Thomas
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. Georg,
- Prof. Dr. Igor,
- PD Dr. Thomas
2018 - 2020
Mitochondria re-distribution of the BCL-2 protein BAX in human hepatocellular carcinoma induces high apoptosis resistance and sensitivity to DNA repair inhibition- Juniorprof. Dr. Jens Uwe,
- Dr. Carolin
2018 - 2021
Identification of cell type specific transcriptional control elements for the development of 2nd generation gene therapy vectors- Univ.-Prof. Dr. Simon